Nisa Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
5,508
+15
| +0.3% | +$326 | ﹤0.01% | 1344 |
|
|
2025
Q1 | $133K | Sell |
5,493
-41
| -0.7% | -$994 | ﹤0.01% | 1328 |
|
|
2024
Q4 | $115K | Buy |
5,534
+243
| +5% | +$5.07K | ﹤0.01% | 1439 |
|
|
2024
Q3 | $105K | Buy |
5,291
+11
| +0.2% | +$219 | ﹤0.01% | 1433 |
|
|
2024
Q2 | $81.8K | Buy |
5,280
+109
| +2% | +$1.69K | ﹤0.01% | 1523 |
|
|
2024
Q1 | $82.4K | Buy |
5,171
+92
| +2% | +$1.47K | ﹤0.01% | 1526 |
|
|
2023
Q4 | $85.4K | Buy |
5,079
+3,829
| +306% | +$64.4K | ﹤0.01% | 1479 |
|
|
2023
Q3 | $14.6K | Hold |
1,250
| – | – | ﹤0.01% | 2099 |
|
|
2023
Q2 | $16.8K | Sell |
1,250
-1,570
| -56% | -$21.1K | ﹤0.01% | 2147 |
|
|
2023
Q1 | $47K | Buy |
2,820
+1,550
| +122% | +$25.8K | ﹤0.01% | 1733 |
|
|
2022
Q4 | $24K | Sell |
1,270
-700
| -36% | -$13.2K | ﹤0.01% | 2007 |
|
|
2022
Q3 | $27K | Sell |
1,970
-350
| -15% | -$4.8K | ﹤0.01% | 1962 |
|
|
2022
Q2 | $16K | Buy |
+2,320
| New | +$16K | ﹤0.01% | 2096 |
|